Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nestle Sa ADR (OP: NSRGY )

85.42 +0.08 (+0.09%)
Streaming Delayed Price Updated: 12:32 PM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nestle Sa ADR

< Previous 1 2 3 4 5 6 Next >
Nightfood Tackling America's $50 Billion Night Snack Problem
Image by Tugol on Shutterstock Nighttime snacking in the United States has exploded in recent years, coinciding with the rise of social media and video streaming. The average... 
Via Benzinga
14 SPACs That Palantir Technologies Has Invested In Or Partnered
Palantir Technologies Inc (NYSE: PLTR) is one of the most well-known publicly traded companies. The data analytics company is increasing its investments in the SPAC space,... 
Via Benzinga
Why Coffee Prices Collapsed? Fundamentals That Will Drive This Volatile Market
A discussion about the recent Brazil coffee frosts and why they resulted in massive spec and fund liquation. What's next? 
Via Talk Markets
Starbucks vs. Coca-Cola: Which Beverage Stock is a Better Buy?
The Coca-Cola Company in Atlanta, Ga., is the world’s largest beverage company, while Starbucks Corporation in Seattle, Wash., is a growing company in this space. 
Via Talk Markets
Faux Fish Set To Expand As Alternative Protein Option
As the alt-meat movement continues to gain acceptance by the public, industry experts say faux fish may soon become the latest craze in alternative protein. Retails sales of plant... 
Via Benzinga
Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
Seres Therapeutics Inc (NASDAQ: MCRB) has inked a $525-million deal with Nestlé Health Science to commercialize SER-109 if it can win FDA approval. SER-109 is an... 
Via Benzinga
Exposures Product Safety
What Are The Climatic Factors Which Would Cocoa Prices Out Of The Doldrums?
The world is addicted to chocolate. That is nothing new. One of the few commodities not to stage a bull market the last few months has been cocoa. This video discusses the reasons why. 
Via Talk Markets
Benson Hill SPAC Deal: The 'Thing Behind The Thing' For Plant-Based Food Market
Benzinga routinely examines a stock that might be considered a little under the radar. The company may not be well known, but chances are the line of work it’s in... 
Via Benzinga
15 European Dividend Aristocrats To Diversify Your Portfolio
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that... 
Via Benzinga
Stocks That May Benefit From Mother’s Day
American’s are expected to spend over $220 on average on their mothers this year. With spending in the tens of billions of dollars, several companies will benefit from all that cash flow. 
Via Talk Markets
3 Upgraded Stocks To Buy In May
I ran a screen to find recently Buy-rated upgraded stocks that were leaders in their industries and offered the potential for growth in the months ahead, and these three top stocks were leading the... 
Via Talk Markets
Nestlé Acquires Bountiful Company's Vitamin Brands From KKR In $5.75B Deal
Nestlé (OTC: NSRGY) is acquiring the core vitamin and supplement brands of The Bountiful Company from KKR & Co. (NYSE: KKR) for $5.75 billion. What Happened: The... 
Via Benzinga
Danimer Scientific Falls After Spruce Point Predicts 65% Share Downside
Shares of bioplastics company Danimer Scientific are falling after Spruce Point Capital Management issued a short report on the name. 
Via Talk Markets
47 Firms Going Ex-Dividend Next Week, Including Nestle, Colgate-Palmolive & CVS Health
There are several well-known large-cap stocks going ex-dividend next week. 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.